Home/Filings/4/0001104659-25-049368
4//SEC Filing

Alexander Robert 4

Accession 0001104659-25-049368

CIK 0001564824other

Filed

May 14, 8:00 PM ET

Accepted

May 15, 4:00 PM ET

Size

19.9 KB

Accession

0001104659-25-049368

Insider Transaction Report

Form 4
Period: 2025-05-15
Alexander Robert
DirectorChief Executive Officer
Transactions
  • Disposition to Issuer

    Common Stock

    2025-05-15738,1040 total
  • Disposition to Issuer

    Stock Option (right to buy)

    2025-05-15912,5000 total
    Exercise: $0.69Exp: 2027-05-17Common Stock (912,500 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2025-05-15306,9600 total
    Exercise: $4.31Exp: 2028-05-15Common Stock (306,960 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2025-05-15462,3250 total
    Exercise: $7.20Exp: 2033-01-06Common Stock (462,325 underlying)
  • Disposition to Issuer

    Common Stock

    2025-05-15320,3000 total(indirect: See footnote)
  • Disposition to Issuer

    Stock Option (right to buy)

    2025-05-15290,0220 total
    Exercise: $4.01Exp: 2028-01-27Common Stock (290,022 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2025-05-15250,0000 total
    Exercise: $35.28Exp: 2028-10-09Common Stock (250,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2025-05-152,000,0000 total
    Exercise: $1.25Exp: 2034-02-16Common Stock (2,000,000 underlying)
Footnotes (4)
  • [F1]Includes 292,810 shares represented by restricted stock units ("RSUs"). Each RSU represents the Reporting Person's right to receive one share of Common Stock of the Issuer.
  • [F2]Disposed of pursuant to the terms of that certain Agreement and Plan of Merger, dated April 1, 2025, by and among the Issuer, Concentra Biosciences, LLC and Concentra Merger Sub III, Inc. (the "Merger Agreement") in exchange for $0.33 in cash per share.
  • [F3]The shares are held by Mr. Alexander and Stacey Lee Alexander, as Trustees of the Alexander 2018 Irrevocable Descendants' Trust.
  • [F4]This option was cancelled without consideration pursuant to the terms of the Merger Agreement.

Issuer

Allakos Inc.

CIK 0001564824

Entity typeother

Related Parties

1
  • filerCIK 0001608782

Filing Metadata

Form type
4
Filed
May 14, 8:00 PM ET
Accepted
May 15, 4:00 PM ET
Size
19.9 KB